ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 78. Num. 2.
Pages 78-81 (February 2025)

Editorial
Revascularization in ischemic cardiomyopathy. Is viability testing still viable?

Revascularización en la miocardiopatía isquémica. ¿Siguen siendo viables los test de viabilidad?

James F. Howick VaBernard J. Gershb

Options

Imagen extra
Rev Esp Cardiol. 2025;78:78-81

Identify yourself

Not yet a subscriber to the journal?

Purchase access to the article

By purchasing the article, the PDF of the same can be downloaded

Price: 19,34 €

Phone for incidents

Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm

Calls from Spain 932 415 960
Calls from outside Spain +34 932 415 960
Copyright © 2024. Sociedad Española de Cardiología
Are you a healthcare professional authorized to prescribe or dispense medications?